MIME-Version: 1.0 Content-Location: file:///C:/2A889913/ADHDReferences.htm Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset="us-ascii" ADHD References

ADHD References

1.= Biederman Joseph, Faraone Stephen, et al: A prospective 4 year Follow-up Study of Attention-Deficit Hyperactivity disorder and Related Disorders. Arch Gen Psychiatry 1996;53:437-446

2 = Child and Adolescent Psychopharmacology Course, Harvar= d Medical School, March 13-15, 1998, Boston, Mass.

3. Barrickman LL, Perry PJ, et al: Buproprion versus Methylphenidate in the Treatment of Attention Deficit Hyperactivity Disorde= r. J Am Acad Child Adolesc Psychiatry 1995, 34,5:649-657.

4. Conners KC, Casat CD, et al: Bupro= pion Hydrochloride in Attention Deficit Disorder with Hyperactivity. J Am Acad Child Adolesc Psychi= atry 1996,35;1314-1321.

5. Cantwell DP: ADHD <= span class=3DGramE>Through the Life Span: the role of Bupropion in treatment. J Clin Psychiatry 1998;59[suppl 4]:92-94.

6. Gerring JP, Brady KD, et. al:= Premorbid Prevalence of ADHD and Development of Secon= dary ADHD after closed head injury. 1998 J Am Acad Child Adolesc Psychiatry 37(6):647-654.

7. Firestone P, Monteiro M, et. al: Short-term Side Effects of Stimulant Medication Are Increased in Preschool Children with ADHD; A Double-Blind Placebo-Controlled Study. Journal of Chi= ld and Adolescent Psychopharmacology 1998 8(1) 13-25.

8.= Pliszka SR: Comorbidity of Attention Deficit Hyperactivity disorder with Psyhc= iatric Disorder: an Overview. J Clin Psychiatry 1998;59[suppl 7]:50-58.

9. Dunner DL, Zisook S, et al: A Prospective Safety Surveillance Study for Buproprion Sustained-Rel= ease in the Treatment of Depression. J Clin Psychiat= ry 1998;59:366-373.

10. Gozal D: Sleep-disordered breathing and school performance in children. Pediatrics 1998 Sep; 102(3 Pt 1): 616-20.

11. Gross-Tsur V Epilepsy and attention deficit hyperactivity disorder: is methylphenidate safe and effective? - J P= ediatr - 1997 Apr; 130(4): 670-4.

12. Brasseux C, D'Angelo LJ, et al: The Changing Patttern of Substance Abuse in Urban Adolescents. Arch Pediatr<= /span> Adolesc Med 1998;152:234-237.

13= .Lavigne JV, Arend R, et al: Psychiatric disorders With = Onset in the Preschool Years: I. Stability of Diagnosis. 1998 J Am Acad Child Adolesc Psychi= atry 37(12):1246-1254

14= .. Lavigne JV, Arend R= , et al: Psychiatric disorders With Onset in the Preschool Year= s:II Correlates and Predictors of Stable Case Status1998 J Am Acad Child Adolesc Psychiatry 37(12):1255-1261.<= o:p>

15. Riggs PD, Leon SL,= et al: An Open Trial of Buproprion ADHD in Adolesc= ents With Substance Use Disorders and Conduct Disorder. 199= 8 J Am Acad Child Adolesc Psychiatry 37(12):1271-1278.

16. Strassberger E ,Donnerstein D: Children, Adolescents,= and the Media: Issues and Solutions (1999) Pediatrics 103:1:126-139.

17. Stevens LJ :Omega-3 fatty acids in boys with behavior, learnin= g, and health problems. Physiol B= ehav (1996)Apr-May; 59(4-5): 915-20.

18. Murphy JM, Pagano ME, et al: the relationship of school breakfas= t to psychosocial and academic functioning. Arch Pediatr Adolesc Med 152:89, 1998. 

19. Kuperman S, Schlosser SS, et al: Relationship of Child Psychopathology to Parental Alcoholism and Antisocial Personality Disorder. J Am Acad Child Adolesc Psychiatry 1999, 38(6):686-69= 2.

 20. Handen BL, Feldman HM et al: Efficacy of Methylphenid= ate Among Preschool Children With Developmental Disabilites and ADHD. . J Am = Acad Child Adolesc Psychiatry 1999, 38(7):805-81= 2.

 21. Gutgesell H, Atkins D, et al: AHA Scientific Statemen= t: cardiovascular Monitoring of Children and Adolescents Receiving Psychotropic Drugs. J Am Acad Child = Adolesc Psychiatry 1999, 38(8):1047-1050.

22. Disney ER, Elkins = IJ, et al: Effects of ADHD, Conduct Disorder, and Gender on Substance use and Abus= e in Adolescence. Am J Psychiatry 1999, 156:1515-1521.

23. Biederman J, Wilens T, et al: Psychoactive substance use disorders in adults with attention-deficit hyperactivity disorder (ADHD) Am J Psychiatry 1995,152: 1652-1658.=

24. Biederman J, et al: Pharmacotherapy of Attention-Deficit Hyperactivity Disorder Reduc= es Risk for Substance Use Disorder Pediatrics 1999;104 August (from internet section of the journal)

25. Cook EH: The Early Development of Child Psychophamacogenetics. . <= i>J Am Acad Child Adolesc = Psychiatry 1999, 38(12) 1478-1481.

26. MTA cooperative gr= oup The Multimodal Treatment Study of Children With = ADHD Arch Gen Psychiatry. 1999;56:1073-1086=

27. MTA cooperative gr= oup: Moderators and Mediators of Treatment Response for Children with ADHD Ar= ch Gen Psychiatry 1999, 56:1088-1096

28= .Mota VL, Schachar RJ: Reformulating Attention-Deficit/Hyperactivity Disorder According to Signal Detection Theo= ry. J Am Acad Child Adolesc Psychiatry2000, 39(9):1144-1151.\

29. Greenhill LL, Swanson = JM et. al: Impairment and Depo= rtment Respinses to Different Methylphenidate Doses in Child= ren with ADHD: the MTA Titration Trial. J Am Acad Child Adolesc Psychiatry2001, 40(2):180-187=

30. Vitiello B, Severe JB, et al: Methylphenidate Dosage for Children with ADHD Over Time Under Controlled conditions: Lessons from th= e MTA. J Am Acad Child Adolesc Psychiatry2001, 40(2):188-196.

31. DuPaul GJ, McGoey KE, et. a= l. : Preschool Children With ADHD: Impairments in Behav= ioral, Social and School Functioning. . J Am Acad C= hild Adolesc Psychiatry2001, 40(5): 508-515=

32= .Ghuman JK, Ginsburg GS, et. al.: Psychostimulants in Preschool Chidlren with ADHD: Clinical Evidence= from a Developmetal Disorders Institution. . J Am= Acad Child Adolesc Psychi= atry2001, 40(5):516-524.

. 33. Voigt RG, Llorente AM, et. al: A randomized, double-blind, placebo-controlled tri= al of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder J Pediatr 2001;139:189-96.

34. Brown TE: DSM-IV: = ADHD and Executive Function Impairments. Advanced Studies in Medicine 2002;2 (25): 910-914.

35. Hazel PL, Stuart JE: A Randomi= zed Controlled Trial of Clonidine Added to Psychostimulant Medication for Hyperactive and Aggres= sive Children. J Am Acad Child Adolesc Psychiatry2001, 42(8):886-894.

36. Swanson J, Gupta S= et al: Development of a New Once-a-Day Formulation of Methylphenidate for the Treatment of Attention-deficit/Hyperactivity Disorder. Arch Gen Psychiatry, 2003;60:204-211.

37. McCracken JT, Biederman J, et al: Analog Classroom Assessment of a = Once-Daily Mixed Amphetamine Formulation, SL1381 (ADDERALL XR) in Children With ADHD. J Am Acad Ch= ild Adolesc Psychiatry 2003 Jun;4= 2(6); 673-688.

38 McGough JJ, Biederman J et al: Pharmacokinetics of SL13= 81 (ADDERALL XR), and Extended -Release Formulation of Ad= derall. J Am Acad Child Adolesc Psychiatry 2003 Jun;42(6); 673-688

39 Rugin= o TA Modafinil in chi= ldren with attention-deficit hyperactivity disorder. Pediatr Neurol<= /i> - 01-AUG-2003; 29(= 2): 136-42

40.  Wilens= T, Dodson W: A Clinical Perspective of ADHD into Adulthood. J cl= in Psychiatry 2004 65: 1301-1313

41. Lee TS: Atomoxetine and tics in ADHD. J Am Acad Child Adolesc Psychiatry - 01-S= EP-2004; 43(9): 1068-9


42. Kratochvil CJ:  Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomi= zed, open-label trial.

J Am Acad Child Adolesc Psychiatry - 01-J= UL-2002; 41(7): 776-84


43. Michelson D: Relapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled study.

- J Am Acad Child Adolesc Psychiatry - 01-J= UL-2004; 43(7): 896-904


44. MD Consult Website: FDA announces new warning for ADHD medication. In  “This Week In Medicine”, December 20, 2004


45. Haag M: Essential fatty acids and the brain.Can= J Psychiatry - 01-APR-2003; 48(3): 195-203


46. Hirayama S: Effect of docosahexaenoic acid-cont= aining food administration on symptoms of attention-deficit/hyperactivity disorder= - a placebo-controlled double-blind study.Eur J Clin Nutr - 01-MAR-2004; 58(3): 467-73


47. = Johnson M, = Ostlund S, et al: Omega-3/omega-6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo-controlled t= rial in children and adolescents. J Atten Diso= rd. 2009 Mar;= 12(5):394-401. Epub 2008 Apr 30.


48. The Oxford-Durham Study: A Randomized, Controlled Trial of Dietary Supplementation With Fatty Acids in Children With Developmental Coordination Disorder PEDIATRICS Vol. 115 No. 5 May 2005, pp. 1360-1366 (doi:10.1542/peds.2004-2164)


49. Richardso AJ, Puri = BK A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptom= s in children with specific learning difficulties. Prog N= europsychopharmacol Biol Psychiatry. 2002 Feb;26(2):233-9.


 50.Ulrike Steuerwald Pal Weihe: Mat= ernal seafood diet, methylmercury exposure, and neona= tal neurologic function J Pediatr 2000;136:599-605<= o:p>


51. Schab DW, Trinh N: Do Artificial Colors Promote Hyperactivity in Children with Hyperactive Syndromes? = Ameta-Analysis of Double-Bl= ind Placebo-Controlled Trials. J Dev Behav <= span class=3DSpellE>Pediatr 25: 423-434, 2004


52.Baldwin RL, Chelonis JJ,et al: Effect of methylphenidate on time perceptio= n in children with attention-deficit/hyperactivity disorder. Exp Clin Psychopharmacol. 2004 Feb;12(1):57-64.

53. Radonovich KJ, Mostofsky= SH: Duration judgments in children with ADHD suggest deficient utilizatio= n of temporal information rather than general impairment in timing. Neuropsychol Dev Cogn C= Child Neuropsychol. 2004 Sep;10(3):162-72.


54. Rasmussen P, Gillberg C Natural outcome of AD= HD with developmental coordination disorder at age 22 years: a controlled, longitudinal, community-based study.J Am Acad Child Adolesc Psyc= hiatry. 2000 Nov;39(11):1424-31


55. Smits MG: Melatonin improves health status and sleep in children with idiopathic chronic sleep-onset insomnia: a randomized placebo-controlled trial.

 J Am Acad Child Adolesc Psychiatry - 01-NOV-2003; 42(11): 1286-= 93.


56. Weiss M, Tannock R et al:A rand= omized, placebo-controlled study of once-daily atomoxetine in the school setting in children with ADHD.
 J Am A= cad Child Adolesc Psychiatry. 2005 Jul;44(7):647-55.


57. Newcorn JH, Spencer TJ et= . Al: Atomoxetine treatment in children and adolescents w= ith attention-deficit/hyperactivity disorder and comorbi= d oppositional defiant disorder. J Am Acad Chil= d Adolesc Psychiatry. 2005 Mar;44= (3):240-8.


58. Cortese S, Konofal E, et al: RLS and ADHD: a Review of the Literature. Sleep 2005;28(8):1007-1013.


59. Guilleminault C :Sleepwal= king and sleep terrors in prepubertal children: wh= at triggers them? Pediatrics - 01-JAN-2003; 111(1): e17-25


60. Konofal E: Ropinirole in a chil= d with attention-defi= cit hyperactivity disorder and restless legs syndrome. <= i>Pediatr Neurol - 01-MAY-2005; 32(5): 350-1


61. Rosen C: Obstructive sleep apnea syndrome in children: controversies in diagnosis and treatment.Pediatr Clin North Am - 01-F= EB-2004; 51(1): 153-67


62. Meltzer LJ, Mindell JA Nonpharmacologic treatments for pediat= ric sleeplessness. Pediatr Clin North Am.<= /a> 2004 Feb;51(1):135-51.


63. Owens JA: The ADHD and sleep conundrum: a review.J Dev Behav Pediatr= - 01-AUG-2005; 2= 6(4): 312-22

64. Donnelly G: Double-blind, Placebo-Controlled, Crossover Study of Multiplayer-Release Methylphenidate in Adult ADHD. Abstract C-19 American= and Canadian Academies of Child and Adolescent Society October 2005 Toronto cited at http://www.pslgroup.com/dg= /25458e.htm


65. PAPPADO= PULOS, ELIZABETH et al: Medication Adherence in the MTA: Saliva Methylphenidate Samples Versus Parent Report= and Mediating Effect of Concomitant Behavioral Treatment Journal of Amer Academy of Child & Adolescent Psychiatry. 48(5):501-510, May 2009.